Neuromyelitis optica: Concepts in evolution

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Neuromyelitis optica (NMO) is a rare demyelinating disease, affecting selectively the optic nerve and the spinal cord. It was previously considered to be a severe variant of multiple sclerosis (MS) due to the similar pathological features and its resemblance to optico-spinal, or Japanese, MS, typical of Asian populations. The finding that most NMO patients have auto-antibodies against aquaporin-4, a water channel particularly abundant on the astrocytes of the glia limitans, has allowed early diagnosis and specific treatment of these patients, and has greatly improved our knowledge of its pathogenesis. When laboratories worldwide can detect anti-aquaporin-4 auto-antibodies with comparable sensitivity and specificity, we will be able to have large multi-centric studies to define better the epidemiological, clinical and pathological features of patients and their responses to treatment.

Original languageEnglish
Pages (from-to)100-104
Number of pages5
JournalJournal of Neuroimmunology
Volume231
Issue number1-2
DOIs
Publication statusPublished - Feb 2011

Fingerprint

Neuromyelitis Optica
Aquaporin 4
Multiple Sclerosis
Aquaporins
Antibodies
Demyelinating Diseases
Optic Nerve
Rare Diseases
Neuroglia
Astrocytes
Early Diagnosis
Spinal Cord
Sensitivity and Specificity
Therapeutics
Population

Keywords

  • Aquaporin-4
  • Devic's disease
  • Multiple sclerosis
  • Myelitis
  • Neuromyelitis optica
  • Optic neuritis

ASJC Scopus subject areas

  • Immunology
  • Clinical Neurology
  • Immunology and Allergy
  • Neurology

Cite this

Neuromyelitis optica : Concepts in evolution. / Fazio, Raffaella; Radaelli, Marta; Furlan, Roberto.

In: Journal of Neuroimmunology, Vol. 231, No. 1-2, 02.2011, p. 100-104.

Research output: Contribution to journalArticle

@article{a310e633b822471b993c3dcdcc40a60b,
title = "Neuromyelitis optica: Concepts in evolution",
abstract = "Neuromyelitis optica (NMO) is a rare demyelinating disease, affecting selectively the optic nerve and the spinal cord. It was previously considered to be a severe variant of multiple sclerosis (MS) due to the similar pathological features and its resemblance to optico-spinal, or Japanese, MS, typical of Asian populations. The finding that most NMO patients have auto-antibodies against aquaporin-4, a water channel particularly abundant on the astrocytes of the glia limitans, has allowed early diagnosis and specific treatment of these patients, and has greatly improved our knowledge of its pathogenesis. When laboratories worldwide can detect anti-aquaporin-4 auto-antibodies with comparable sensitivity and specificity, we will be able to have large multi-centric studies to define better the epidemiological, clinical and pathological features of patients and their responses to treatment.",
keywords = "Aquaporin-4, Devic's disease, Multiple sclerosis, Myelitis, Neuromyelitis optica, Optic neuritis",
author = "Raffaella Fazio and Marta Radaelli and Roberto Furlan",
year = "2011",
month = "2",
doi = "10.1016/j.jneuroim.2010.10.012",
language = "English",
volume = "231",
pages = "100--104",
journal = "Journal of Neuroimmunology",
issn = "0165-5728",
publisher = "Elsevier Science B.V.",
number = "1-2",

}

TY - JOUR

T1 - Neuromyelitis optica

T2 - Concepts in evolution

AU - Fazio, Raffaella

AU - Radaelli, Marta

AU - Furlan, Roberto

PY - 2011/2

Y1 - 2011/2

N2 - Neuromyelitis optica (NMO) is a rare demyelinating disease, affecting selectively the optic nerve and the spinal cord. It was previously considered to be a severe variant of multiple sclerosis (MS) due to the similar pathological features and its resemblance to optico-spinal, or Japanese, MS, typical of Asian populations. The finding that most NMO patients have auto-antibodies against aquaporin-4, a water channel particularly abundant on the astrocytes of the glia limitans, has allowed early diagnosis and specific treatment of these patients, and has greatly improved our knowledge of its pathogenesis. When laboratories worldwide can detect anti-aquaporin-4 auto-antibodies with comparable sensitivity and specificity, we will be able to have large multi-centric studies to define better the epidemiological, clinical and pathological features of patients and their responses to treatment.

AB - Neuromyelitis optica (NMO) is a rare demyelinating disease, affecting selectively the optic nerve and the spinal cord. It was previously considered to be a severe variant of multiple sclerosis (MS) due to the similar pathological features and its resemblance to optico-spinal, or Japanese, MS, typical of Asian populations. The finding that most NMO patients have auto-antibodies against aquaporin-4, a water channel particularly abundant on the astrocytes of the glia limitans, has allowed early diagnosis and specific treatment of these patients, and has greatly improved our knowledge of its pathogenesis. When laboratories worldwide can detect anti-aquaporin-4 auto-antibodies with comparable sensitivity and specificity, we will be able to have large multi-centric studies to define better the epidemiological, clinical and pathological features of patients and their responses to treatment.

KW - Aquaporin-4

KW - Devic's disease

KW - Multiple sclerosis

KW - Myelitis

KW - Neuromyelitis optica

KW - Optic neuritis

UR - http://www.scopus.com/inward/record.url?scp=79952449289&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952449289&partnerID=8YFLogxK

U2 - 10.1016/j.jneuroim.2010.10.012

DO - 10.1016/j.jneuroim.2010.10.012

M3 - Article

C2 - 21067820

AN - SCOPUS:79952449289

VL - 231

SP - 100

EP - 104

JO - Journal of Neuroimmunology

JF - Journal of Neuroimmunology

SN - 0165-5728

IS - 1-2

ER -